Estimates Revisions Highnoon Laboratories Limited

Stocks

End-of-day quote Pakistan S.E. 2026-09-11			5-day change	1st Jan Change
924.60 ^PKR	+1.50%		-0.66%	-9.57%

Aug. 27	Highnoon Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
May. 18	Highnoon Laboratories Appoints Dr. Shahzad Khan as Managing Director of Highnoon Life Sciences	CI

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	1y. Revenue rev.	1y. EPS revision
	HIGHNOON LABORATORIES LIMITED			-
	ELI LILLY AND COMPANY
	JOHNSON & JOHNSON
	ABBVIE INC.
	ROCHE HOLDING AG
	NOVARTIS AG
	ASTRAZENECA PLC
	AMGEN INC.
	NOVO NORDISK A/S
	GILEAD SCIENCES, INC.
	Average
	Weighted average by Cap.